4
Changes in Ownership
HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-19-058834
Executive VP, Drug Development sold 24,000 shares at $26.00 ($624,000)
- Executive VP, Drug Development acquired 24,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
MANHARD KIMBERLY · Executive VP, Drug Development
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-11-29 | Exercise or conversion : show line 1 in the form | +24,000 | $13.00 | $312,000 | 24,000 | D |
| 2019-11-29 | Sale : show line 2 in the form | −24,000 | $26.00 | $624,000 | 0 | D |
| Open-market sales · 24,000 sh · avg $26.00 · $624,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2019-11-29 | Exercise or conversion : show line 3 in the form Employee Stock Option (Right to Buy) | −24,000 | $13.00 | 2026-12-21 | 24,000 | 58,416 | D |
Loading xslF345X03/doc4.xml…